Delivery Order SPE2DE24D0013-SPE2D625F0ZFT
- Not listed
- The Defense Logistics Agency's Medical Supply Chain has awarded a $7,904 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, designated XPCOV2/FLU/RSV-10, represents procurement of diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract was awarded on September 8, 2025, with an ultimate completion date of September 15, 2025, and carries no...
- The U.S. Defense Logistics Agency, through the Medical Supply Chain division, awarded a $4,080 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on June 18, 2025, with an ultimate completion date of June 26, 2025, is designated as XPCOV2/FLU/RSV-10 and carries no set-aside designation. The delivery order addresses federal requirements for COVID-19, influenza, and respiratory syncytial virus...
- The Defense Logistics Agency issued a $34,223.80 firm fixed-price delivery order to Cepheid Inc. on September 15, 2025, for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic testing supplies and services. The contract, designated as XPCOV2/FLU/RSV-10, carries an ultimate completion date of September 22, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. This delivery order does not utilize a set-aside designation and represents a continuation of...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a $14,448 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and will be performed at Cepheid's...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain program, awarded a $8,995.14 firm fixed-price delivery order to Cepheid Inc. on May 6, 2025, for molecular diagnostic solutions with an ultimate completion date of May 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, references testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV)—aligning with Cepheid's core diagnostic product offerings. The contract carries no set-aside...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $17,000 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 19, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus testing. The contract, designated as XPCOV2/FLU/RSV-10, has an ultimate completion date of August 26, 2025, and will be performed at Cepheid's headquarters in Sunnyvale, California. No small business set-aside was utilized for...
- The U.S. Defense Logistics Agency (Medical Supply Chain) awarded a $12,086.88 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The delivery order, issued on August 6, 2025, with completion targeted for August 13, 2025, is designated XPCOV2/FLU/RSV-10 and carries no set-aside designation. This award represents a delivery order issued under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts, likely the...
- The U.S. Defense Department's Medical Supply Chain division awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. (Sunnyvale, CA) on April 23, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated XPCOV2/FLU/RSV-10, carries an ultimate completion date of April 30, 2025, and involves no set-aside provisions. This delivery order represents procurement activity under Cepheid's existing indefinite...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order valued at $3,400 to Cepheid Inc. on September 2, 2025, with an ultimate completion date of September 9, 2025. The contract, designated 4569302264, is for XPCOV2/FLU/RSV-10 products and services and carries a firm fixed-price structure with no set-aside designation. The work will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit molecular diagnostics...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded Cepheid Inc. a delivery order valued at $22,240 on September 9, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV). This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by September 16, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F0ZFTDelivery Order
The Defense Logistics Agency, under its Medical Supply Chain division, awarded a $13,547.30 firm fixed-price delivery order to Cepheid Inc. on August 14, 2025, for respiratory and influenza diagnostic solutions. The contract, designated as XPCOV2/FLU/RSV-10, is scheduled for completion by August 21, 2025, and will be performed at Cepheid's Sunnyvale, California facility. This delivery order carries no set-aside designation and represents procurement under one of Cepheid's existing federal vehicles, enabling the company to supply molecular diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. Cepheid is a specialized manufacturer of molecular diagnostic systems and reagents based in Sunnyvale, California, with an established track record of supplying diagnostic solutions across federal healthcare systems. The company maintains significant indefinite delivery contracts with the Department of Veterans Affairs, including a $32.8 million IDV with VA's Veterans Integrated Service Network 6 and a $2.5 million IDV with VA's Veterans Integrated Service Network 21, both supporting PCR-based diagnostic testing for infectious diseases. This delivery order aligns with Cepheid's core business of providing GeneXpert diagnostic systems and associated test kits to federal agencies for rapid infectious disease detection and diagnosis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.5k | 8/14/25 |